Published in Cancer Weekly, March 25th, 2008
"In patients with locally advanced disease, the cancer-specific survival rate after RP at 5-and 10-yr follow-up was 85-100% and 57-91.6%, respectively. The overall survival rate at 5 and 10 yr was >75% and 60%, respectively. In patients with high-grade...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.